Pr Hélène Dollfus, ERN-EYE coordinator, received the Special Recognition Award in appreciation of her tireless comittment to retina and rare disease patients.
Unlocking the potential for rare disease therapies through wider collaborations between European Reference Networks and industry
Prominent MEPs seeking quicker wins for rare disease patients are backing closer collaboration between ERNs and pharma companies through a novel multistakeholder initiative.